Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
COHANCE LIFESCIENCES LTD.
Cohance Lifesciences Ltd.
NSE: COHANCE | BSE: 543064
Expensive Underperformer
Download real time
425.95
-16.00
(
-3.62
%)
New 52W Low today
553.3K
NSE+BSE Volume
NSE
16 Jan, 2026 3:31 PM (IST)
Watchlist
Portfolio
Alert
My Notes
TRADE STOCK
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Cohance Lifesciences Corporate Filings & Announcements
Latest corporate announcements and filings from Cohance Lifesciences on BSE
Get corporate announcements alerts
Hourly Digest
Daily Digest
All
News
Earnings Calls
Corporate Announcements
Research Reports
Load latest
VOTE: Is Suven Pharmaceuticals Ltd. worth buying?
39 Votes:
Buy
69.23%
Sell
17.95%
Hold
12.82%
BUY
SELL
HOLD
RESEARCH REPORTS
Sell
SEE REPORTS >
13 Nov 2025
pdf
Cohance Lifesciences..
by ICICI Securities Limited
| Target:
640
Target met
Buy
SEE REPORTS >
29 May 2025
pdf
Cohance Lifesciences..
by ICICI Securities Limited
| Target:
1365
| Upside:
220.46%
All reports of COHANCE